Recruiting soon

MAP-ENDEarly Neurovascular Decoupling Trajectories in Acute Ischemic Stroke Patients After Revascularization

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This observational study aims to examine the changes in a composite neurovascular decoupling index from Day 1 to Day 7 after revascularization in acute ischemic stroke patients, using Transcranial Doppler, Electroencephalography, and F-wave persistence measurements.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Ischemic Stroke+5

+ Brain Diseases

+ Cardiovascular Diseases

From 18 to 85 Years
+12 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: February 2026
See protocol details

Summary

Principal SponsorXijing Hospital
Study ContactLang JinMore contacts
Last updated: February 13, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 5, 2026

Actual date on which the first participant was enrolled.

This study focuses on understanding the recovery process after a successful revascularization treatment for acute ischemic stroke, a condition caused by blockages in blood vessels leading to the brain. Despite successful treatment, patients often experience varying levels of functional recovery, which is not well understood. The study aims to explore the changes in the brain's blood flow and neural activity connection, known as neurovascular coupling, in the early days after treatment. It is believed that these changes may impact the patient's long-term recovery. The study will observe adult patients who have undergone successful endovascular thrombectomy within 24 hours of stroke symptoms. During the study, participants will undergo multimodal monitoring, which includes Transcranial Doppler (TCD), Electroencephalography (EEG), and F-wave studies. These tests measure cerebral hemodynamic status, cortical neuroelectrical activity, and spinal anterior horn motoneuron excitability, respectively. The study will track these measurements at different time points: within 24-72 hours post-thrombectomy, at Day 7, and at Day 90. The goal is to identify patterns in these measurements that can predict a patient's functional outcome 90 days after the stroke.

Official TitleMechanisms of Recovery Phenotypes: Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke Using Multimodal Monitoring
NCT07405762
Principal SponsorXijing Hospital
Study ContactLang JinMore contacts
Last updated: February 13, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

180 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 85 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Ischemic StrokeBrain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesCerebrovascular DisordersNervous System DiseasesVascular DiseasesStroke

Criteria

5 inclusion criteria required to participate
Age between 18 and 85 years

Acute ischemic stroke due to occlusion of the anterior circulation large vessel (terminal internal carotid artery, or M1/M2 segment of the middle cerebral artery), confirmed by computed tomography angiography (CTA) or magnetic resonance angiography (MRA).

Underwent endovascular thrombectomy with successful reperfusion, defined as a post-procedural modified Thrombolysis in Cerebral Infarction (mTICI) grade of 2b or 3.

Time from symptom onset to femoral artery puncture is ≤ 24 hours.

Show More Criteria

7 exclusion criteria prevent from participating
Pregnancy or lactation.

Pre-stroke disability defined as a modified Rankin Scale (mRS) score ≥ 2.

Inadequate temporal bone window preventing acquisition of stable blood flow signals by Transcranial Doppler (TCD).

Concurrent severe organ failure, malignancy, or a life expectancy of less than 3 months.

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
Recruiting soonNo study centers
MAP-END | Early Neurovascular Decoupling Trajectories in Acute Ischemic Stroke Patients After Revascularization | PatLynk